AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT03028740 · TERMINATED
Trial details
- NCT number
- NCT03028740
- Sponsor
- Tobira Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2021-01-12
- Enrollment
- 1778
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.